bioRxiv · 10.1101/2022.08.02.502100
NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids
Abstract
As SARS-CoV-2 continues to spread worldwide, tractable primary airway cell models that accurately recapitulate the cell-intrinsic response to arising viral variants are needed. Here we describe an adult stem cell-derived human airway organoid model overexpressing the ACE2 receptor that supports robust viral replication while maintaining 3D architecture and cellular diversity of the airway epithelium. ACE2-OE organoids were infected with SARS-CoV-2 variants and subjected to single-cell RNA-sequencing. NF-{kappa}B inhibitor alpha was consistently upregulated in infected epithelial cells, and its mRNA expression positively correlated with infection levels. Confocal microscopy showed more I{kappa}B expression in infected than bystander cells, but found concurrent nuclear translocation of NF-{kappa}B that I{kappa}B usually prevents. Overexpressing a nondegradable I{kappa}B mutant reduced NF-{kappa}B translocation and increased viral infection. These data demonstrate the functionality of ACE2-OE organoids in SARS-CoV-2 research and identify an incomplete NF-{kappa}B feedback loop as a rheostat of viral infection that may promote inflammation and severe disease.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Simoneau, C. R., Chen, P.-Y., Xing, G. X., Khalid, M. M., Meyers, N. L., Hayashi, J. M., Taha, T. Y., Leon, K. E., Ashuach, T., Fontaine, K. A., Rodriguez, L., Joehnk, B., Walcott, K., Vasudevan, S., Fang, X., Maishan, M., Schultz, S., Roose, J., Matthay, M. A., Sil, A., Arjomandi, M., Yosef, N., Ott, M.. 2022-08-02. NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids. https://doi.org/10.1101/2022.08.02.502100
Cite the original work for its findings. Save a collection to share your selection of sources.